Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy
The Journal of Allergy and Clinical Immunology, 07/18/2012
Clinical Article
Savage JH et al. – The clinical response to omalizumab occurs early in treatment when the basophil, but not the mast cell, is suppressed, supporting a role for the basophil in acute food reactions.



